Evidence map›Paper›PMID 40034117›Full record

ArticleiScience2025

An enhancing diagnostic pulmonary diseases diagnostic method for differentiating talaromycosis from tuberculosis.

Ying Zhou, Pengchen Lin, Lijing Xia, Ali Asghar Heidari, Yi Chen, Lei Liu, Huiling Chen, Chengye Li, Yuping Li

Abstract read
In one paragraph

Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ying ZhouDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Pengchen LinDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Lijing XiaDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Ali Asghar HeidariSchool of Surveying and Geospatial Engineering, College of Engineering, University of Tehran, Tehran, Iran.
Yi ChenKey Laboratory of Intelligent Informatics for Safety & Emergency of Zhejiang Province, Wenzhou University, Wenzhou 325035, China.
Lei LiuCollege of Computer Science, Sichuan University, Chengdu, Sichuan 610065, China.
Huiling ChenCollege of Computer Science and Artificial Intelligence, Wenzhou University, Wenzhou 325035, P.R. China.
Chengye LiDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Yuping LiDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Talaromycosis (TSM) affects immunocompromised individuals, particularly those with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), causing varied pulmonary abnormalities on chest computed tomography (CT). These features overlap with pulmonary tuberculosis, making accurate differentiation essential for appropriate treatment. This study utilized real patient data from the First Affiliated Hospital of Wenzhou Medical University. A machine learning model, termed bIPCACO-FKNN, was developed, integrating an ant colony optimization (ACO) algorithm with a fuzzy k-nearest neighbors (FKNNs) classifier. This model introduces an incremental proportional-integral-derivative control strategy to enhance the search efficiency of ACO. Comparative analysis with several algorithms in the CEC 2017 benchmark functions confirms the superior performance of the IPCACO. Applying the bIPCACO-FKNN model for the prediction of pulmonary TSM achieved a prediction accuracy of 98.196% and a specificity of 99.500%, thus demonstrating its significant efficacy in accurately distinguishing between pulmonary TSM and tuberculosis. This provides an efficient and reliable machine learning tool for the differentiation between pulmonary TSM and tuberculosis.

Indexed as

Machine learningPublic health

Identifiers

PMID40034117
PMCPMC11872622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.